A detailed history of Snowden Capital Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 110,318 shares of NVO stock, worth $11.6 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
110,318
Previous 100,131 10.17%
Holding current value
$11.6 Million
Previous $14.3 Million 8.1%
% of portfolio
0.4%
Previous 0.43%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $1.21 Million - $1.48 Million
10,187 Added 10.17%
110,318 $13.1 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $206,643 - $247,396
1,684 Added 1.71%
100,131 $14.3 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $399,556 - $531,854
3,913 Added 4.14%
98,447 $12.6 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $3.29 Million - $3.95 Million
37,464 Added 65.65%
94,534 $9.78 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $1.69 Million - $3.7 Million
18,557 Added 48.18%
57,070 $5.19 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $1.84 Million - $2.04 Million
11,816 Added 44.26%
38,513 $6.23 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $211,611 - $254,464
-1,599 Reduced 5.65%
26,697 $4.25 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $140,493 - $185,402
1,370 Added 5.09%
28,296 $3.83 Million
Q3 2022

Nov 09, 2022

SELL
$95.28 - $116.93 $5.11 Million - $6.27 Million
-53,664 Reduced 66.59%
26,926 $2.68 Million
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $7.03 Million - $8.29 Million
68,064 Added 543.38%
80,590 $8.98 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $651,420 - $787,442
6,997 Added 126.55%
12,526 $1.39 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $530,120 - $647,335
5,529 New
5,529 $619,000
Q3 2021

Feb 05, 2024

SELL
$84.42 - $106.62 $3.87 Million - $4.89 Million
-45,831 Reduced 80.31%
11,239 $1.08 Billion
Q2 2021

Jan 08, 2024

BUY
$67.66 - $84.76 $134,305 - $168,248
1,985 Added 24.39%
10,123 $848 Million
Q1 2021

Jan 08, 2024

BUY
$67.06 - $75.82 $221,633 - $250,585
3,305 Added 68.38%
8,138 $549 Million
Q4 2020

Jan 08, 2024

BUY
$63.89 - $73.8 $308,780 - $356,675
4,833 New
4,833 $338 Million
Q1 2020

Jan 08, 2024

SELL
$49.46 - $64.78 $313,675 - $410,834
-6,342 Closed
0 $0
Q4 2019

Jan 30, 2024

SELL
$49.86 - $58.26 $2.53 Million - $2.96 Million
-50,728 Reduced 88.89%
6,342 $367 Million
Q4 2019

Jan 08, 2024

SELL
$49.86 - $58.26 $17 Million - $19.8 Million
-340,158 Reduced 98.17%
6,342 $367 Million
Q3 2019

Jan 08, 2024

BUY
$47.54 - $53.43 $16.5 Million - $18.5 Million
346,500 New
346,500 $179 Million
Q1 2019

Jan 08, 2024

SELL
$46.36 - $52.63 $341,765 - $387,988
-7,372 Closed
0 $0
Q4 2018

Jan 08, 2024

SELL
$41.54 - $47.25 $23,968 - $27,263
-577 Reduced 7.26%
7,372 $340 Million
Q3 2018

Jan 08, 2024

BUY
$46.76 - $51.24 $67,334 - $73,785
1,440 Added 22.12%
7,949 $375 Million
Q2 2018

Jan 08, 2024

BUY
$44.29 - $50.42 $15,280 - $17,394
345 Added 5.6%
6,509 $300 Million
Q1 2018

Jan 08, 2024

SELL
$48.49 - $58.14 $2.47 Million - $2.96 Million
-50,906 Reduced 89.2%
6,164 $304 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.